Wan Chuchuan, Li Haotao, Zhang Yulin, Wang Qiqi, Huang Yiwen, Guan Tao, Xi Xiaoyu
The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, 639 Longmian Avenue, Jiangning District, Nanjing, Jiangsu Province, China.
School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Orphanet J Rare Dis. 2025 Aug 7;20(1):407. doi: 10.1186/s13023-025-03894-y.
Obtaining health-state utility values (HSUVs) aids in making scientific decisions in patient health management, especially for rare disease patients. However, there is currently no research specifically measuring the HSUVs of Chinese hemophilia B patients. Therefore, this study aims to assess the HSUVs of hemophilia B patients in China and explore its potential influencing factors.
The sociodemographic characteristics of patients were obtained from the Beijing Hemophilia Home Care Center (BHHCC) database. And the HSUVs were further obtained by reaching hemophilia B patients through an application of BHHCC and the Chinese version of the EQ-5D-5L. The beta regression model was used to explore the potential influencing factors of the HSUVs of patients.
A total of 167 male patients (hemophilia B is an X-chromosome recessive disorder and female patients are rare) were included in the study. The mean age, HSUV and EQ-VAS were 20.01 ± 15.83, 0.755 ± 0.291 and 71.7 ± 22.7, respectively. The ceiling effects was 29.24%, and patients were more likely to experience problems in Pain/discomfort (57.49%). Compared to self-completion, proxy may overestimate HSUVs of patients. Pain (p < 0.000), disability (p < 0.000), complications (p < 0.001), inhibitors (p < 0.01), drug usage (p < 0.001), and bleeds (p < 0.000) were significantly associated with HSUVs in Chinese hemophilia B patients.
This study first assessed the HSUVs of Chinese hemophilia B patients, which provides support for further economic studies. Potential factors that affect the HSUVs of Chinese hemophilia B patients were also explored, which can provide a reference for developing health management measures. However, to enact more comprehensive and reliable disease management decisions, the effects of self-completion and proxy on the HSUVs of hemophilia B patients in China need to be further explored as well as the effects of specific factors.
获取健康状态效用值(HSUVs)有助于在患者健康管理中做出科学决策,尤其是对于罕见病患者。然而,目前尚无专门针对中国乙型血友病患者HSUVs的研究。因此,本研究旨在评估中国乙型血友病患者的HSUVs,并探讨其潜在影响因素。
从北京血友病家庭护理中心(BHHCC)数据库获取患者的社会人口学特征。通过BHHCC应用程序和中文版EQ-5D-5L联系乙型血友病患者,进一步获取HSUVs。使用β回归模型探讨患者HSUVs的潜在影响因素。
本研究共纳入167例男性患者(乙型血友病是一种X染色体隐性疾病,女性患者罕见)。平均年龄、HSUV和EQ-VAS分别为20.01±15.83、0.755±0.291和71.7±22.7。天花板效应为29.24%,患者在疼痛/不适方面更易出现问题(57.49%)。与自我完成相比,代理人可能高估患者的HSUVs。疼痛(p<0.000)、残疾(p<0.000)、并发症(p<0.001)、抑制剂(p<0.01)、药物使用(p<0.001)和出血(p<0.000)与中国乙型血友病患者的HSUVs显著相关。
本研究首次评估了中国乙型血友病患者的HSUVs,为进一步的经济学研究提供了支持。还探讨了影响中国乙型血友病患者HSUVs的潜在因素,可为制定健康管理措施提供参考。然而,要做出更全面、可靠的疾病管理决策,还需要进一步探讨自我完成和代理人对中国乙型血友病患者HSUVs的影响以及特定因素的影响。